ABIGAIL SOUTHALL: Open Payments
NPI 1861006066 · LEBANON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 77 payments from 21 companies in 2025. Trend: 2023 $1,260 · 2024 $1,374 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $268 |
| Axsome Therapeutics, Inc. | 7 | $172 |
| Vanda Pharmaceuticals Inc. | 9 | $139 |
| Viatris Specialty LLC | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $64 |
| Novo Nordisk Inc | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Amgen Inc. | 3 | $52 |
Products named: Auvelity, VRAYLAR, FANAPT, YUPELRI, Kerendia, GEMTESA, XIFAXAN, REXULTI.
Industry payments across KY — which companies pay providers there.
